Page 49 - OR-1-1

1. Introduction as 3D bioprinting, microfluidics, and high-throughput
8
9
screening. As a result, the ability to generate complex
10
Organoids, 3D cellular aggregates that mimic the structure organoid models has expanded beyond basic research
and function of human tissues have emerged as one of the into clinical and therapeutic applications. 11-14 These
most transformative innovations in biomedical research. developments have not only enhanced our understanding
Unlike traditional 2D cell cultures or animal models, of human biology but also opened new avenues for drug
organoids offer a more physiologically relevant alternative, discovery, toxicity testing, and even patient-specific
recapitulating complex tissue architectures, cellular treatments. However, while the progress is significant, the
15
heterogeneity, and functional dynamics. This ability field faces several hurdles that must be addressed to fully
1
to model human-specific biology has made organoids harness the potential of organoids in clinical practice.
16
indispensable tools for studying diseases, screening drugs, Various challenges remain major bottlenecks, including
and advancing regenerative medicine. From modeling the standardization of protocols, scalability for high-
cancer to understanding neurodegenerative diseases and throughput applications, and the integration of immune
bone disorders, organoids are proving to be invaluable and vascular systems within organoid models. 17,18
platforms for personalized medicine. 2-4
In response to the rapid advancements and emerging
At present, the evolution of biomedical research models challenges in organoid research, we established Organoid
has transitioned from traditional 2D cell cultures to animal Research as a dedicated platform to foster innovation and
models and now to organoids, reflecting a progressive disseminate high-impact studies in this dynamic field. The
enhancement in physiological relevance and application journal aims to bridge the gap between basic science and
potential (Figure 1). While 2D cell cultures offer excellent clinical applications, focusing on significant conceptual,
manipulability and low cost, they fail to replicate complex experimental, and translational advances in organoid
tissue environments and lack integration of vascular and technologies. Organoid Research welcomes submissions
19
5
immune systems. Animal models, on the other hand, across diverse areas, including stem cell biology, tissue
provide physiologically accurate representations but face engineering, regenerative medicine, disease modeling,
limitations in scalability, ethical concerns, and technical and drug discovery. 20,21 We encourage papers that explore
complexity. Organoids, as a semi-physiological system, bioengineered organoids, organoid-based systems biology,
6
strike a balance by combining high-throughput screening and the integration of organoids with clinical research. 16,22,23
and genome editing capabilities with improved clinical Special emphasis is placed on research advancing novel
relevance and regenerative medicine potential. Despite approaches in organoid development, incorporating
7
their advantages, organoids still require advancements in cutting-edge bioengineering techniques, materiobiology,
vascularization and immune system integration to fully and integrative technologies, such as artificial intelligence
replicate the complexity of human tissues, paving the way (AI), high-throughput screening, and precision medicine.
24
for more robust and translatable models in biomedical The journal also values contributions that address
research. Organoids offer several advantages over other ethical considerations and the challenges of clinical
advanced in vitro models, such as microfluidic organ-on-a- translation. With a commitment to timely peer review
chip systems and 3D spheroid cultures. While microfluidic and publication, Organoid Research seeks to be the leading
systems excel in mimicking physiological environments platform for scientists, engineers, and clinicians at the
and studying multi-organ interactions, they often lack tissue forefront of organoid technology, driving interdisciplinary
complexity and are costly and complex to manufacture. collaboration and advancing groundbreaking applications
Similarly, 3D spheroid cultures, while simple and effective in science and medicine.
in enhancing cell-cell interactions, lack the complex tissue
In this perspective, we aim to systematically explore
architecture and differentiation potential of organoids. In the present state of organoid research from three critical
contrast, organoids not only closely replicate the histological dimensions: Theory, technology, and therapeutics. We
and molecular features of human tissues but also maintain provide an in-depth review of emerging theoretical
genetic stability during long-term culture. Their utility is frameworks that guide the construction and maturation of
further highlighted by their ability to be expanded and organoid models, highlight key technological innovations
derived from patient samples for personalized medicine. shaping the field, and examine the expanding therapeutic
As a result, organoids have emerged as a powerful tool in potential of organoids in clinical settings. Furthermore,
biomedical research, providing a more reliable and versatile we address the key challenges that continue to hinder
platform for disease modeling and drug development.
the broader adoption of organoids, proposing solutions
In recent years, organoid research has seen rapid to overcome these obstacles and outlining the promising
advancement, driven by breakthroughs in stem cell biology, future directions in organoid research. By offering a
tissue engineering, and biomedical technologies, such comprehensive overview of the field, this perspective seeks

Volume 1 Issue 1 (2025) 2 doi: 10.36922/OR025040007